[go: up one dir, main page]

UY27140A1 - VEHICLE WITH SOLID FIBRINOGEN AND SOLID THROMBIN. - Google Patents

VEHICLE WITH SOLID FIBRINOGEN AND SOLID THROMBIN.

Info

Publication number
UY27140A1
UY27140A1 UY27140A UY27140A UY27140A1 UY 27140 A1 UY27140 A1 UY 27140A1 UY 27140 A UY27140 A UY 27140A UY 27140 A UY27140 A UY 27140A UY 27140 A1 UY27140 A1 UY 27140A1
Authority
UY
Uruguay
Prior art keywords
acid
solid
vehicle
fibrinogen
thrombin
Prior art date
Application number
UY27140A
Other languages
Spanish (es)
Inventor
Alfred Schaufler
Original Assignee
Nycomed Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Pharma As filed Critical Nycomed Pharma As
Publication of UY27140A1 publication Critical patent/UY27140A1/en

Links

Landscapes

  • Materials For Medical Uses (AREA)

Abstract

La presente invención se refiere a una composición sólida útil para el pegado de tejidos, sellado de tejidos y para Hemostasis, que consiste esencialmente en a) un vehículo que tiene al menos una de las siguientes propiedades físicas: módulo de elasticidad en el intervalo de 5-100 N/cm, densidad de 1-10mg/cm3, diámetro de cámara mayor que 0.75 mm y menor que 4mm y/o que tiene un diámetro medio de cámara inferior a 3mm y distribuido uniformemente y fijado sobre dicho vehículo, b) fibrinógeno sólido, y c) trombina sólida. El vehículo es un polímero biodegradable tal como un ácido polihialurónico, ácido polihidroxilado, por ejemplo ácido láctico, ácido gulocólico, ácido hidroxibutanoico, una celulosa, gelatina o colágeno, tal como una esponja de colágeno que consiste esencialmente en fibras de colágeno de tipo I. El fibrinógeno y la trombina son preferiblemente humanos transgénicos o recombinantes. En una realización preferida, la composición no comprende ningún agente antifibrinolítico tal como aprotinina, ácido e-aminocaproico o alfa2-antiplasmina.The present invention relates to a solid composition useful for tissue bonding, tissue sealing and hemostasis, which essentially consists of a) a vehicle having at least one of the following physical properties: modulus of elasticity in the range of 5 -100 N / cm, density of 1-10mg / cm3, chamber diameter greater than 0.75 mm and less than 4mm and / or having an average chamber diameter less than 3mm and evenly distributed and fixed on said vehicle, b) fibrinogen solid, and c) solid thrombin. The carrier is a biodegradable polymer such as a polyhyaluronic acid, polyhydroxylated acid, for example lactic acid, gulocolic acid, hydroxybutanoic acid, a cellulose, gelatin or collagen, such as a collagen sponge consisting essentially of type I collagen fibers. The fibrinogen and thrombin are preferably transgenic or recombinant human. In a preferred embodiment, the composition does not comprise any antifibrinolytic agent such as aprotinin, e-aminocaproic acid or alpha2-antiplasmin.

UY27140A 2001-02-13 2002-01-25 VEHICLE WITH SOLID FIBRINOGEN AND SOLID THROMBIN. UY27140A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200100235 2001-02-13

Publications (1)

Publication Number Publication Date
UY27140A1 true UY27140A1 (en) 2002-07-31

Family

ID=34877998

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27140A UY27140A1 (en) 2001-02-13 2002-01-25 VEHICLE WITH SOLID FIBRINOGEN AND SOLID THROMBIN.

Country Status (1)

Country Link
UY (1) UY27140A1 (en)

Similar Documents

Publication Publication Date Title
AR032400A1 (en) AN AGENT WITH A SOLID FIBRINOGEN AND A SOLID THROMBIN
Mizraji et al. Membrane barriers for guided bone regeneration: An overview of available biomaterials
ES2532428T3 (en) Hemostatic sponge
RU2545810C2 (en) Device for fastening haemostasis and/or wound healing
CN102939113B (en) Hemostatic sponge
EP0804595B1 (en) Resorbable synthetic proteins as implantables
ATE359836T1 (en) POROUS CERAMIC COMPOSITE BONE IMPLANTS
CA2513319A1 (en) Hemostatic material comprising thrombin, fibrinogen and bioabsorbable synthetic nonwoven fabric
BR9811000A (en) "polymeric compositions"
DE69428312D1 (en) Absorbable composites for use in the treatment of tooth root canal diseases
CA2295247A1 (en) Compositions containing thrombin and microfibrillar collagen
KR20040047538A (en) Hemostatic wound dressing containing aldehyde-modified polysaccharide and hemostatic agents
RU2009118939A (en) METHOD FOR MAKING BANDAGES
Clark Fibrin sealant in wound repair: a systematic survey of the literature
WO2004028465A3 (en) Hemostatic compositions and methods
US20140271610A1 (en) Collagen and alginate-based formulations for hemostasis
WO2000015248A3 (en) Growth factor-containing composition for healing tissue damage
DE69903945D1 (en) THREE-DIMENSIONAL BIOMATERIALS, FREE OF CELLULAR COMPONENTS AND PRODUCTS, CONTAINING HYALURONIC ACID DERIVATIVES, FOR IN-VIVO REGENERATION OF TISSUE CELLS
UY27140A1 (en) VEHICLE WITH SOLID FIBRINOGEN AND SOLID THROMBIN.
ATE373733T1 (en) FIBRIN CONTAINING LONG STRETCH BIOPOLYMER STRUCTURE
WO2000009175A1 (en) Topically absorbent hemostatic material
ES8502343A1 (en) Synthetic absorbable hemostat.
UA74046C2 (en) Solid composition containing solid fibrinogen and solid thrombin which is useful for tissue gluing, tissue sealing and bleeding arrest, method for gluing and sealing tissues, method for bleeding arrest
Haarer et al. Proteins and amino acid-derived polymers
Amin et al. Advancement of guided tissue regeneration (GTR) membranes for dental applications

Legal Events

Date Code Title Description
110 Patent granted

Effective date: 20180115

VENC Patent expired

Effective date: 20220125